UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or o ...

Exponent, Inc. (NASDAQ:EXPO) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting, IR Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Josh Chan - UBS Operator Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. [Operator Instructions] Please note, this even ...

Exponent (EXPO) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.33%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.40 per share when it actually produced earnings of $0.46, delivering a surprise of 15%.Over the last ...

Exponent (EXPO) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, and welcome to the Exponent, Inc. First Quarter twenty twenty five Earnings Conference Call. All participants will be in the listen only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your telephone keypad. To withdraw your question, please press then 2. Please note this event is being recorded. I would now like to turn the conference over to Jon ...

Exponent (EXPO) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Company Participants Joni Konstantelos - Investor RelationsCatherine Corrigan - President and Chief Executive OfficerRich Schlenker - Executive Vice President and Chief Financial Officer.Jasper Bibb - Vice President Equity Research Conference Call Participants Andrew Nicholas - Equity Research AnalystJosh Chan - Executive Director - Equity Research Analyst Operator Good day, and welcome to the Exponent, Inc. First Quarter twenty twenty five Earn ...

Revenue Performance - Total revenues for Q1 2025 were approximately flat at $145.5 million, compared to $144.9 million in Q1 2024[5] - Exponent anticipates low-single digit revenue growth for the full fiscal year 2025 compared to fiscal year 2024[10] - The engineering and other scientific segment accounted for 84% of revenues before reimbursements, remaining flat year-over-year[8] - The environmental and health segment represented 16% of revenues before reimbursements, with a 2% increase driven by the chemicals industry[9] Income and Profitability - Net income decreased to $26.7 million, or $0.52 per diluted share, down from $30.1 million, or $0.59 per diluted share in Q1 2024[6] - EBITDA decreased to $37.5 million, representing 27.3% of net revenues, compared to $40.1 million, or 29.2% of net revenues in Q1 2024[7] - Exponent's operating income for Q1 2025 was $44.4 million, compared to $30.7 million in Q1 2024[22] - Net income for the quarter ended April 4, 2025, was $26,650 million, a decrease of 4.9% from $30,142 million in the same quarter of 2024[28] - EBITDA for the quarter was $37,538 million, down 6.4% from $40,121 million year-over-year[28] - EBITDAS for the quarter was $45,717 million, a decline of 3.7% compared to $47,461 million in the previous year[28] Expenses and Taxation - Income taxes increased to $11,110 million from $10,281 million, reflecting a rise of 8.1%[28] - Stock-based compensation rose to $8,179 million, up 11.4% from $7,340 million in the prior year[28] - Depreciation and amortization expenses increased to $2,492 million, compared to $2,324 million, marking a growth of 7.2%[28] - Interest income, net, was $(2,714) million, slightly higher than $(2,626) million in the previous year[28] - The consolidated tax rate for Q1 2025 was 29.4%, up from 25.4% in Q1 2024[6] Cash and Dividends - The company plans to maintain its quarterly cash dividend of $0.30, with $16.4 million paid in dividends during Q1 2025[7] - Exponent closed the quarter with $245.1 million in cash and cash equivalents[7] Operating Performance Measures - The company emphasizes that EBITDA and EBITDAS are useful measures of operating performance and cash flow, providing meaningful comparisons of past, present, and future results[29] - Management believes that non-GAAP measures like EBITDA and EBITDAS should be considered in addition to GAAP measures for a comprehensive view of financial performance[29] - The company continues to focus on enhancing operating performance despite the decline in net income and EBITDA metrics[29]

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are ...

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. “Exponent’s first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver,” said Dr. Catherine Corrigan, President and Chief Executive Officer. “Our failure analysis expertise drove increased dispute-related activities in the chemicals, transportation and uti ...

Core Insights - Exponent, Inc. will report its First Quarter of fiscal year 2025 financial results on May 1, 2025, after market close [1] - The conference call to discuss the financial results will be hosted by Dr. Catherine Corrigan and Richard Schlenker at 4:30 p.m. ET [1][2] - A live and archived webcast of the conference call will be available on the company's Investor Relations website [2] Company Overview - Exponent integrates over 90 technical disciplines with more than 950 consultants to assist clients in navigating complex industry challenges [3] - The company focuses on failure analysis and developing solutions aimed at creating a safer, healthier, and more sustainable world [3] - Exponent's consultants leverage multidisciplinary expertise and resources globally, providing insights to various sectors including multinational companies, startups, law firms, and governments [4]

Exponent Inc. (NASDAQ: EXPO ) is a little-followed consulting company. That said, it is a market leader and has consistently grown in the past decade. Consulting for safety, litigation, regulation, accidents, and failures is a unique business that grows with time. The dividend yield is low, the dividendI am a self-taught individual investor and I have been investing in stocks for over 25 years. I focus on dividend growth investing with a long-term horizon since I believe in the compounding power of dividend ...